ISV-303 (bromfenac in DuraSite)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISV-303 (bromfenac in DuraSite), covering 2016-07-13 to 2016-07-13. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers [Phase 1, Phase 2]